C-Bond Systems, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Details Textual)

Shareholders' Deficit (Details Textual) - USD ($)																										1 Months Ended														3 Months Ended	12 Months Ended
Shareholders' Deficit (Details Textual) - USD ($)	Apr. 07, 2021	Mar. 08, 2021	Jan. 07, 2021	Jan. 06, 2021	Dec. 18, 2020	Oct. 09, 2020	Oct. 07, 2020	Oct. 06, 2020	Oct. 02, 2020	Aug. 24, 2020	Jul. 02, 2020	May 08, 2020	Apr. 17, 2020	Apr. 02, 2020	Apr. 01, 2020	Jan. 13, 2020	Dec. 12, 2019	Nov. 19, 2019	Oct. 02, 2019	Aug. 15, 2019	Jul. 29, 2019	Jul. 18, 2019	Jul. 12, 2019	Mar. 14, 2019	Mar. 12, 2019	Mar. 19, 2021	Feb. 01, 2021	Sep. 30, 2020	Aug. 31, 2020	Aug. 20, 2020	Apr. 28, 2020	Feb. 20, 2020	Feb. 18, 2020	Nov. 30, 2019	Nov. 30, 2019	Oct. 31, 2019	Jul. 29, 2019	May 20, 2019	Dec. 27, 2016	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2019	Jan. 18, 2021	Dec. 21, 2020	Dec. 14, 2019	Dec. 09, 2019	Sep. 14, 2019	Sep. 06, 2019	Jun. 14, 2019
Shareholders' Deficit (Textual)
Preferred Stock par value																																								$ 0.10	$ 0.10	$ 0.10
Conversion fees																																									$ 2,500
Amortization of debt discount																																									424,001	$ 160,542
Accrued interest																																								$ 36,244	$ 36,244
Common shares issued for debt conversion, shares					547,945								203,125																												37,171,800
Amount of common stock upon conversion																				$ 12,000																						12,000
Shares of common stock upon conversion																				295,567
Common shares per share						$ 0.012		$ 0.008					$ 0.08			$ 0.04		$ 0.05
Accrued dividends																																								6,031	$ 6,031
Accrued compensation																	$ 108,000																											$ 318,970
Shares of grant restricted stock award of common shares						500,000		1,275,000										510,000
Value of grant restricted stock award of common shares						$ 6,000		$ 10,200										$ 25,500
Stock-based compensation					$ 4,603																																				609,662	1,783,099
Interest expense																																									751,184	343,078
Issuance of common shares for services, amount																																									149,475	202,360
Stock-based professional fees								$ 10,200										$ 25,500																							$ (132,892)	$ (355,393)
Non-vested shares																																										323,373
Common share exercise compensation, shares																																									16,132,701
Recognized compensation expense																																										$ 7,500
Total unrecognized compensation expense related to unvested common shares																																								$ 446,064	$ 446,064	2,068,368
Weighted average period																																									1 year
Cash proceeds from investor																$ 6,058																									$ 117,047
Warrant exercise price reduced																																								$ 0.01	$ 0.01
Fair value of the award amount					12,603
Aggregate principal amount																																										135,833
Unrecognized compensation expense																																									110,650
Convert of deferred compensation					$ 8,000								$ 16,250
Fair market value of per share					$ 0.023								$ 0.055
Sale of common shares, shares																151,456
Exercise of stock options, value																																										19,185
Reduced accrued compensation																				$ 90,000
Recorded settlement expense
Increase decrease in accounts payable																																									139,300	239,605
Increase decrease in accrued expenses																																									96,022	89,266
Shares issued for deferred compensation, description														The Company entered into two one-year advisory board agreements with two individuals for services to be rendered on the Company's medical advisory board. In connection with these advisory board agreements, the Company issued an aggregate of 500,000 restricted common shares of the Company to these advisory board members. These shares vest on April 1, 2021. These shares were valued at $20,000, or $0.04 per common share, based on contemporaneous common share sales by the Company. In connection with this consulting agreement, during the year ended December 31, 2020, accretion of stock-based consulting fees amounted to $15,000 and the remaining stock-based consulting fees of $5,000 shall be accreted over the remaining vesting period.
Conversion of principal balance																																									152,285
Issued shares of common stock																				3,000,000
Accrued dividend payable										$ 1,562																															4,852
Investor and redeemed										103,200
Redemption penalties										$ 12,285
Remaining put premium balance																																									24,207
Gain on extinguishment																																									24,207
Conversion Price																																									450,204
Research and development expense																																									16,627	31,057
Stock-based professional fees																																									$ 6,000
Vesting period																																									May 01, 2021
Subsequent Event [Member]
Shareholders' Deficit (Textual)
Issued shares of common stock	2,500,000	750,000	1,008,000	100,000																						944,767	900,000
Former Chief Executive Officer [Member]
Shareholders' Deficit (Textual)
Common shares per share																					$ 0.05		$ 0.04														$ 0.05
Convert of deferred compensation																							$ 80,000														$ 40,000
Convert shares of common stock																							2,000,000														800,000
Chief Operating Officer[Member]
Shareholders' Deficit (Textual)
Common shares per share																						$ 0.04
Convert of deferred compensation																						$ 80,000
Convert shares of common stock																						2,000,000
Fair market value of per share																						$ 0.04
Employees [Member]
Shareholders' Deficit (Textual)
Common shares per share																						$ 0.04
Convert of deferred compensation																						$ 24,000
Convert shares of common stock																						600,000
President and Chief Operating Officer [Member]
Shareholders' Deficit (Textual)
Common shares per share																					0.05																$ 0.05
Convert of deferred compensation																																					$ 50,000
Convert shares of common stock																																					1,000,000
Fair market value of per share																																					$ 0.05
Consulting Agreement [Member]
Shareholders' Deficit (Textual)
Common shares per share							$ 0.0085																		$ 0.17							$ 0.04						$ 0.094
Shares of grant restricted stock award of common shares							9,000,000																		485,060							1,250,000						500,000
Value of grant restricted stock award of common shares							$ 76,500																		$ 82,460													$ 47,000
Stock-based professional fees																									$ 82,460													$ 47,000			$ 50,000
Employment Agreements [Member]
Shareholders' Deficit (Textual)
Common shares per share														$ 0.04
Shares of grant restricted stock award of common shares														200,000
Value of grant restricted stock award of common shares														$ 8,000
Patent Expense Reimbursement Agreement [Member]
Shareholders' Deficit (Textual)
Common shares per share									$ 0.011
Shares of grant restricted stock award of common shares									25,000
Value of grant restricted stock award of common shares									$ 275
Research and development expense									$ 275
Marketing Agreement
Shareholders' Deficit (Textual)
Common shares per share																			$ 0.044
Shares of grant restricted stock award of common shares																			350,000
Value of grant restricted stock award of common shares																			$ 15,400
Stock-based professional fees																			$ 15,400
Restricted Stock Award Agreements [Member]
Shareholders' Deficit (Textual)
Common shares per share																					$ 0.04										$ 0.04			$ 0.05	$ 0.05		$ 0.04
Shares of grant restricted stock award of common shares																					10,500,000										6,750,000				1,300,000
Value of grant restricted stock award of common shares																					$ 525,000										$ 270,000				$ 65,000
Percentage of restricted shares																					100.00%										100.00%			100.00%	100.00%		100.00%
Employment agreement [Member]
Shareholders' Deficit (Textual)
Common shares per share															$ 0.04
Shares of grant restricted stock award of common shares															200,000
Value of grant restricted stock award of common shares															$ 8,000
Letter Agreement [Member]
Shareholders' Deficit (Textual)
Stock-based professional fees																																									$ 0	$ 159,700
Exercise price																								$ 0.18
Risk-free rate																																									2.43%
Dividend yield																																									0.00%
Expected term																																									5 years
Expected volatility																																									275.00%
Fair value of the award amount																																									$ 159,700
Warrants to purchase shares																								1,000,000
Purchase Agreements [member]
Shareholders' Deficit (Textual)
Exercise price																																														$ 0.10		$ 0.10
Fair value of the award amount																																									$ 61,899
Warrants to purchase shares																																														1,050,000		1,050,000
Purchase Agreements [member] \| Subsequent Event [Member]
Shareholders' Deficit (Textual)
Warrants to purchase shares			1,050,000
Cashless exercise of warrants			1,008,000
Investor [Member]
Shareholders' Deficit (Textual)
Common shares per share											$ 0.013	$ 0.023				$ 0.04																	$ 0.04									$ 0.15
Cash proceeds from investor											$ 280,000	$ 161,000				$ 280,000																	$ 280,000									$ 300,000
Sale of common shares, shares											21,538,462	7,000,000				7,000,000																	7,000,000									2,000,000
Investor [Member]
Shareholders' Deficit (Textual)
Common shares per share																																								$ 0.054	$ 0.054
Cash proceeds from investor																																									$ 100,000	$ 480,000
Sale of common shares, shares																																									1,851,852	10,750,000
Investor [Member] \| Maximum [Member]
Shareholders' Deficit (Textual)
Common shares per share																																										$ 0.05
Investor [Member] \| Minimum [Member]
Shareholders' Deficit (Textual)
Common shares per share																																										$ 0.04
Dinosaur Financial Group, LLC [Member] \| Letter Agreement [Member]
Shareholders' Deficit (Textual)
Exercise price																								$ 0.18																					$ 0.07		$ 0.05		$ 0.08
Warrants to purchase shares																								200,000																					200,000		200,000		400,000
Equity Option [Member]
Shareholders' Deficit (Textual)
Exercise price																																							$ 0.31
Exercise of stock options, shares																																							750,000
Exercise of stock options, value																																							$ 5,000		$ 182,500	$ 182,500
Warrants [Member]
Shareholders' Deficit (Textual)
Exercise price																																								0.10	$ 0.10
Warrant exercise price reduced																																								$ 0.003	$ 0.003
Warrant purchase, description																																									On March 30, 2020 and on April 23, 2020, in connection with Purchase Agreements with an accredited investor (See Note 6), the Company issued warrants to purchase an aggregate amount up to 288,750 shares of the Company’s common stock (the “Warrants”). The Warrants were exercisable at any time on or after the date of the issuance and entitled this investor to purchase shares of the Company’s common stock for a period of five years from the initial date the warrants become exercisable. Under the terms of the Warrants, the holder was entitled to exercise the Warrants to purchase up to 288,750 shares of the Company'sCompany’s common stock at an initial exercise price of $0.10, subject to adjustment as detailed in the Warrants. In connection with the issuance of the warrants, on the initial measurement date, the relative fair value of the warrants of $14,498 was recorded as a debt discount and an increase in paid-in capital (See Note 6). In September 2020, in connection with the repayment of the debt, these warrants were cancelled.
Preferred Stock [Member]
Shareholders' Deficit (Textual)
Accrued dividend payable																																									$ 2,476
2018 Long-term Incentive Plan [Member]
Shareholders' Deficit (Textual)
Common shares per share																								$ 0.16
Shares of grant restricted stock award of common shares																								200,000
Value of grant restricted stock award of common shares																								$ 32,000
Aggregate shares of common stock issued without any minimum vesting period																																									25,000,000
Aggregate number of common stock issued under plan																																									50,000,000
Incentive stock options																																								11,445,698	11,445,698
Description of options to acquire common stock																																									The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company's common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company's outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.
Restricted stock have been issued																																								$ 25,951,070	$ 25,951,070
Percentage of restricted shares																								100.00%
Advisory Board Agreement [Member]
Shareholders' Deficit (Textual)
Stock-based professional fees																																									6,667	$ 25,333
Consulting Agreement [Member]
Shareholders' Deficit (Textual)
Stock-based professional fees																																									6,500
Consulting Agreement [Member]
Shareholders' Deficit (Textual)
Stock-based professional fees																																									38,250
Prepaid expenses																																								$ 38,250	$ 38,250
Series A Preferred Stock [Member]
Shareholders' Deficit (Textual)
Shares designated																																								0	0	800,000
Preferred Stock par value																																		$ 0.10	$ 0.10	$ 0.10				$ 0.10	$ 0.10	$ 0.10
Preferred stock stated value																																								$ 1.00	$ 1.00
Preferred Stock dividend Rate																																									4.00%
Preferred stock dividend increased																																									22.00%
Conversion price converted into market price																																									81.00%
Market price representing at discount rate																																									19.00%
Debt premium																																									$ 42,553
Debt premium charge to interest expenses																																									$ 31,197
Preferred stock unregistered shares																																		159,600	159,600	159,600				154,800	154,800
Preferred stock unregistered value																																		$ 133,000	$ 133,000	$ 133,000				$ 129,000	$ 129,000
Cash proceeds																																		127,000		127,000					120,000
Net of fees																																		6,000		6,000					9,000
Amortization of debt discount																																									9,000
Amortization of discount charged to interest expense																																		$ 6,000		$ 6,000					14,333	$ 667
Accrued interest																																										$ 934
Debt premium to paid-in capital.																																								49,543	49,543
Stated value																																								$ 211,200	$ 211,200
Common shares per share																																		$ 0.833	$ 0.833	$ 0.833				$ 0.833	$ 0.833
Accrued dividends																																								$ 4,224	$ 4,224
Fully redeemed value																																								$ 0	0
Interest expense																																									$ 126,423
Description of options to acquire common stock																																									The Company issued 16,132,701 shares its common stock upon the conversion of 211,200 shares of Series A preferred with a stated redemption value of $211,200 and related accrued dividends payable of $4,224. The conversion price was based on contractual terms of the related Series A preferred shares. Upon conversion, the Company reclassified put premium of $49,543 to paid-in capital.
Series C Preferred Stock [Member]
Shareholders' Deficit (Textual)
Shares designated																																								100,000	100,000	100,000
Preferred Stock par value																																								$ 0.10	$ 0.10	$ 0.10
Preferred stock stated value																																								$ 100.00	$ 100.00
Preferred stock unregistered value																																								$ 630,000	$ 630,000
Series B Preferred Stock [Member]
Shareholders' Deficit (Textual)
Shares designated																	100,000																							100,000	100,000	100,000
Preferred Stock par value																	$ 0.10																							$ 0.10	$ 0.10	$ 0.10
Preferred Stock dividend Rate																	2.00%
Stated value																	$ 1,000
Accrued compensation																																											$ 295,000
Series A preferred stock balance																																								$ 429,446	$ 429,446	$ 108,000
Liquidation value																																								$ 426,970	426,970	$ 108,000
Stock-based compensation																																									1,048,143
Stock option, description																	The Series B is convertible at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the "Conversion Price").
Accrued dividend payable																																									2,476
Series B Convertible Preferred Stock [Member]
Shareholders' Deficit (Textual)
Settlement of accrued compensation																	108																											319
Series C Convertible Preferred Stock [Member]
Shareholders' Deficit (Textual)
Preferred stock stated value																												$ 100	$ 100
Preferred Stock dividend Rate																														2.00%
Preferred Stock shares value																												630,000	630,000
Purchase of shares																												6,300	6,300
Designations established share																														100,000
Series C Convertible Preferred Stock [Member] \| Subscription Agreements [Member]
Shareholders' Deficit (Textual)
Agreement description																																								The Company entered into subscription agreements with an accredited investor whereby the investor agreed to purchase an aggregate of purchase 7,000 shares of the Company's Series C Convertible Preferred Stock for $700,000, or $100.00 per share (the "Stated Value"), which were used from working capital purposes.
Series C Preferred Stock [Member]
Shareholders' Deficit (Textual)
Preferred Stock par value																														$ 0.10
Common shares per share																														$ 100
Series C Preferred Stock [Member]
Shareholders' Deficit (Textual)
Stated value																																								$ 1,330,000	1,330,000
Accrued dividends																																								6,031	6,031
Series C preferred stock balance																																								1,336,031	1,336,031
Percentage of redeemed value																														150.00%
Non-cash deemed dividend																																								$ 1,525,873	$ 1,525,873